Promoter holding
64.27%
NT
Novel Tissues Private Limited - Due diligence report
A 360° intelligence report on Novel Tissues: trust score, financial health, credit view, compliance, directors, growth and distress signals …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Novel Tissues — 360° Intelligence Report
Generated from MCA filings & public records77/100
Trust Score
Low Risk
Novel Tissues is assessed as Low Risk with a Trust Score of 77/100. Novel Tissues is an active private limited indian non-government company incorporated in 2003, operating in the Manufacturing sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 04 Aug 2026 from the latest processed filings. Novel Tissues Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 12 open (32.05 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Sidbi | 7 | 48.0 cr |
| Canara Bank | 4 | 48.0 cr |
| The Canara Bank Ltd | 1 | 48.0 cr |
Compliance Score: 45/100 Caution Indicated
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2023 - filings overdue.
- Flagged by authority: MCA, EPFO.
- 4 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ADAVIAPPA BALAPPA DODDAMANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| LAVA BASANINGAPPA DODDAMANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
| Group entity | Relationship | % held |
|---|---|---|
| Shree Mallikarjuna Sugars Limited | Associate Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 38% in a year.
Statutory filings appear overdue.
Compliance score is weak (45/100).
12 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 12 open charge(s) of 32.05 cr already registered.
- Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events19 Mar 2025
Charge created
Sidbi - 2.00 cr
28 Jun 2024
Charge created
Sidbi - 5.95 cr
Charge created
Sidbi - 2.00 cr
30 Sep 2023
Last AGM held
Annual general meeting
31 Mar 2023
Latest balance sheet
Filed with ROC
21 Mar 2023
Charge created
Canara Bank - 60.00 Lakh
16 Jun 2022
Charge created
Sidbi - 6.95 cr
29 Mar 2022
Charge created
Sidbi - 6.35 cr
24 Jun 2020
Charge created
Sidbi - 2.70 cr
08 May 2020
Charge created
Sidbi - 50.00 Lakh
06 Jun 2018
Charge created
Canara Bank - 1.00 cr
11 Nov 2013
Director appointed
LAVA BASANINGAPPA DODDAMANI (Director)
Director ceased
MALLIKARJUNA BALAPPA
25 Sep 2013
Director ceased
EMMANUEL VARKEY CHEMPOTTICKAL
29 Oct 2012
Director ceased
MITTU MALLAPPA IRANNA
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
4 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Kk Lighting | U74999HR2018PTC074954 | Kundli, Haryana, India |
| Id Smart Cards Creations Private Limited | U74140KA2003PTC032758 | Indiranagar,Bangalore., Karnataka, India |
| Zenium | U74950MH1997PLC108689 | Mira Road, Maharashtra, India |
| Marudhar Stones International Private Limited | U14100KA2007PTC044697 | Bangalore South, Karnataka, India |
| B. R. Steel Products Private Limited | U99999MH1960PTC011799 | Navi Mumbai, Maharashtra, India |
| Woodbridge | U25206DL2006PTC152496 | Delhi, Delhi, India |
| Camrola Quartz Limited | U74999GJ2017PLC099231 | Ahmedabad, Gujarat, India |
| Sri Jaya Sakthi Edibile Oils Private Limited | U15141TZ2004PTC011396 | Salem, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Novel Tissues before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Novel Tissues: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Novel Tissues - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Novel Tissues pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Novel Tissues - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Novel Tissues an active company?
Novel Tissues has MCA status “Active” with a compliance score of 45/100 (Caution Indicated).
Is Novel Tissues financially healthy?
Novel Tissues has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Novel Tissues?
Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Novel Tissues?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Novel Tissues have loans or charges against its assets?
12 open charge(s) are registered against its assets.
Is Novel Tissues up to date with its ROC filings?
Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 45/100 (Caution Indicated).
Is it risky to lend to Novel Tissues?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
